Aster DM Quality Care Q1 FY27 profit crashes 81% to ₹16 crore despite revenue surge
Synopsis
Aster DM Quality Care's net profit collapsed 81% to ₹16.1 crore in Q1 FY27 even as revenues surged 21.6% — a stark divergence that points squarely at merger-related costs from the integration of Aster DM Healthcare and Quality Care India. On a combined proforma basis, the merged entity is now a ₹2,597 crore quarterly revenue platform, which changes the scale of the story entirely.
Key Takeaways
Aster DM Quality Care reported a 81.2 per cent fall in net profit to ₹16.1 crore in Q1 FY27 , down from ₹85.5 crore in Q1 FY26.
Revenue from operations rose 21.6 per cent year-on-year to ₹1,311 crore .
EBITDA grew 27.5 per cent to ₹264.3 crore ; EBITDA margin improved to 20.2 per cent from 19.2 per cent .
Total patient volumes grew 16 per cent year-on-year; emerging hospitals posted 95 per cent revenue growth.
On a combined proforma basis post-merger, the entity reported revenue of ₹2,597 crore and EBITDA of ₹576 crore , up 30 per cent .
Shares closed 0.2 per cent lower at ₹833 ahead of the results announcement.
Aster DM Quality Care posted a sharp 81.2 per cent decline in consolidated net profit to ₹16.1 crore in the first quarter of FY27 (April–June 2026), even as revenues and operating earnings climbed strongly. The healthcare company had recorded a net profit of ₹85.5 crore in the same quarter a year ago, according to its stock exchange filing.
Revenue and Operating Performance
Revenue from operations grew 21.6 per cent year-on-year to ₹1,311 crore in Q1 FY27, up from ₹1,078 crore in Q1 FY26. The growth was driven by higher patient footfalls and stronger performance across both mature and emerging hospitals.
At the operating level, EBITDA rose 27.5 per cent to ₹264.3 crore from ₹207.4 crore in the year-ago period. EBITDA margin improved to 20.2 per cent from 19.2 per cent, reflecting improving operational efficiency across the hospital network.
Patient Volumes and Hospital Growth
Total patient volumes grew 16 per cent year-on-year during the quarter. Revenue from mature hospitals rose 19 per cent, while emerging hospitals recorded a sharp 95 per cent increase in revenue, supported by rising utilisation levels and expanding healthcare demand across markets.
Merger Impact: Combined Proforma Numbers
The quarter also marked a significant corporate milestone — the formation of Aster DM Quality Care following the integration of Aster DM Healthcare and Quality Care India. On a combined proforma basis, the merged entity reported revenue of ₹2,597 crore during the quarter, up 20 per cent year-on-year.
Combined operating EBITDA rose 30 per cent to ₹576 crore, with EBITDA margin expanding by 170 basis points to 22.2 per cent. The combined platform served nearly 2 million outpatient and inpatient visits, a 13 per cent increase from the year-ago period.
What the Management Said
Varun Khanna, Managing Director and Group CEO, described the merger as a significant milestone, noting that the combined entity's scale and operational integration position it for sustained growth. The company said its focus will remain on integrating operations, improving efficiencies, and strengthening patient care delivery across its expanded network.
Market Reaction and Outlook
Shares of Aster DM Quality Care ended 0.2 per cent lower at ₹833 ahead of the earnings announcement on Wednesday, 5 August 2026. The disconnect between robust operating metrics and the steep profit decline is likely to draw investor scrutiny, particularly around below-the-line costs associated with the merger integration. The company's ability to convert improving EBITDA into bottom-line growth will be closely watched in the quarters ahead.
Point of View
But the operating picture tells a different story — EBITDA grew 27.5 per cent and margins expanded. The gap almost certainly reflects merger-integration costs that are compressing the bottom line in the near term. The more consequential number is the combined proforma revenue of ₹2,597 crore, which signals that the Aster-Quality Care merger has created a materially larger platform. The real test is how quickly management can eliminate integration drag and translate strong EBITDA into net profit recovery — and whether the 95 per cent revenue surge in emerging hospitals is structural or a base-effect anomaly.
NationPress
6 Aug 2026
Frequently Asked Questions
Why did Aster DM Quality Care's net profit fall so sharply in Q1 FY27?
Aster DM Quality Care's net profit fell 81.2 per cent to ₹16.1 crore in Q1 FY27, down from ₹85.5 crore a year ago, despite strong revenue and EBITDA growth. The decline is attributed to costs associated with the merger integration of Aster DM Healthcare and Quality Care India, which weighed heavily on the bottom line.
How did Aster DM Quality Care's revenue perform in Q1 FY27?
Revenue from operations rose 21.6 per cent year-on-year to ₹1,311 crore in Q1 FY27, compared with ₹1,078 crore in Q1 FY26. Growth was driven by higher patient footfalls and strong performance across both mature and emerging hospitals.
What is the Aster DM Healthcare and Quality Care India merger?
Aster DM Quality Care was formed through the integration of Aster DM Healthcare and Quality Care India, creating a combined healthcare platform. On a proforma basis, the merged entity reported quarterly revenue of ₹2,597 crore and served nearly 2 million patient visits in Q1 FY27.
How did Aster DM Quality Care's EBITDA perform despite the profit fall?
EBITDA grew 27.5 per cent to ₹264.3 crore in Q1 FY27, and EBITDA margin improved to 20.2 per cent from 19.2 per cent a year earlier. On a combined proforma basis, operating EBITDA rose 30 per cent to ₹576 crore with margins expanding 170 basis points to 22.2 per cent.
How did Aster DM Quality Care shares react to the Q1 FY27 results?
Shares of Aster DM Quality Care ended 0.2 per cent lower at ₹833 on 5 August 2026, ahead of the earnings announcement. The muted market reaction reflected the mixed nature of the results — strong operating metrics offset by the steep net profit decline.
